Clinical Trial Update: Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating nebulized 3% hypertonic saline for acute bronchiolitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• 3% hypertonic saline (nebulized) (sodium chloride 3% solution)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Bronchiolitis | Phase 4 | Status: WITHDRAWN